• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OXGN:US

1.8600 USD 0.0100 0.53%

As of 17:10:00 ET on 11/28/2014.

Snapshot for OXiGENE Inc (OXGN)

Open: 1.8700 Day's Range: 1.8300 - 1.8800 Volume: 107,063
Previous Close: 1.8700 52wk Range: 1.6800 - 5.4000 1-Yr Rtn: -31.37%

Stock Chart for OXGN

No chart data available.
  • OXGN:US 1.8600
  • 1D
  • 1M
  • 1Y
1.8700
Interactive OXGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OXGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1870
Est. EPS (USD) (12/2014) -0.7950
Est. PEG Ratio -
Market Cap (M USD) 38.51
Shares Outstanding (M) 20.71
30 Day Average Volume 895,122
Price/Book (mrq) 1.2196
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OXGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OXGN

OXiGENE Inc. is a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.

David J Chaplin "Dai"President/CEOBarbara RichingVP/CFO
More Company Profile & Key Executives for OXGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil